APVO Stock Analysis: Buy, Sell, or Hold?
APVO - Aptevo Therapeutics Inc
$6.76
-0.78 (-10.34%)
▼
5d:
-18.16%
30d:
-28.01%
90d:
+336.13%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Feb 13, 2026
8d
Get Alerted When APVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: APVO is down 18.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: APVO is down 18.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: APVO is currently trading at $6.76, which is considered slightly low relative to its 30-day fair value range of $6.58 to $10.14.
Technical Outlook: Technically, APVO is in a strong uptrend. Immediate support is located at $6.53, while resistance sits at $9.97. Short-term momentum is weak, with the stock down 10.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $378.00 (+5491.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APVO is in a strong uptrend. Immediate support is located at $6.53, while resistance sits at $9.97. Short-term momentum is weak, with the stock down 10.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $378.00 (+5491.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$6.58 -
$10.14
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.3%)
- BULLISH: Trading 5491.7% below Wall St target ($378.00)
- WARNING: Recommendation downgraded due to -18.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$6.58 -
$10.14
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.53
Resistance Level
$9.97
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.23
Wall Street Target
$378.00
(+5491.7%)
Revenue Growth (YoY)
-100.0%
Last updated: February 04, 2026 2:07 AM ET
Data refreshes hourly during market hours. Next update: 3:07 AM
Data refreshes hourly during market hours. Next update: 3:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 67 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 65 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
